You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ophthalmic%20Solutions

Showing 26 - 50 of 2,869
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Presbyopia Trial in Glendale, Memphis (0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo)

Recruiting
  • Presbyopia
  • 0.1% STN1013600 ophthalmic solution
  • +2 more
  • Glendale, California
  • +1 more
Jan 12, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

Recruiting
  • Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
  • Aichi, Japan
  • +15 more
Aug 16, 2022

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting
  • Allergic Conjunctivitis
  • Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
  • +3 more
  • Phoenix, Arizona
  • +2 more
Nov 9, 2022

Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • Topical spironolactone ophthalmic solution, 0.005 mg/cc
  • Placebo
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Aug 16, 2023

Dry Eye Trial in Raynham (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Raynham, Massachusetts
    Andover Eye Associates (Raynham)
Aug 2, 2022

Dry Eye Syndromes Trial in Andover (IC265 Ophthalmic Solution 1%, Placebo Ophthalmic Solution (Vehicle))

Not yet recruiting
  • Dry Eye Syndromes
  • IC265 Ophthalmic Solution 1%
  • Placebo Ophthalmic Solution (Vehicle)
  • Andover, Massachusetts
    Iacta Selected Site
Aug 8, 2023

Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution

Recruiting
  • Dry Eye Disease
  • SY-201 Ophthalmic Solution 2.0%
  • +3 more
  • Durham, North Carolina
    Lexitas
Jul 27, 2022

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • Eye drops for itchy and water eyes
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Dry Eye Syndromes Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Dry Eye Syndromes
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
Jun 22, 2022

Glaucoma, Primary Open Angle, Ocular Hypertension Trial in Newport Beach (Study Treatment 1 WB007, Study Treatment 2 WB007,

Active, not recruiting
  • Glaucoma, Primary Open Angle
  • Ocular Hypertension
  • Study Treatment 1 WB007
  • +3 more
  • Newport Beach, California
    Eye Research Foundation
Dec 30, 2022

Acute Bacterial Conjunctivitis Trial (IVIEW-1201, Ofloxacin Eye Drops)

Not yet recruiting
  • Acute Bacterial Conjunctivitis
  • (no location specified)
Apr 13, 2023

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Test - Bimatoprost 0.01% Ophthalmic Solution, Reference -

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Test - Bimatoprost 0.01% Ophthalmic Solution
  • Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
  • Newport Beach, California
  • +8 more
Aug 9, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, Latanoprost ophthalmic

Recruiting
  • Primary Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • Latanoprost ophthalmic solution 0.005%
  • Aichi, Japan
  • +42 more
Aug 9, 2022

Dry Eye Disease Trial in United States (A197 Ophthalmic Solution, A197 Vehicle Control, Active Comparator)

Active, not recruiting
  • Dry Eye Disease
  • A197 Ophthalmic Solution
  • +2 more
  • Birmingham, Alabama
  • +23 more
Nov 8, 2022

Dry Eye Trial in New York (Lifitegrast 5% Ophthalmic Solution, Lifitegrast Ophthalmic Solution Vehicle)

Not yet recruiting
  • Dry Eye
  • Lifitegrast 5% Ophthalmic Solution
  • Lifitegrast Ophthalmic Solution Vehicle
  • New York, New York
    State University of New York College of Optometry Clinical Visio
Aug 16, 2022

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
Has Results
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
May 5, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Olivos, Buenos Aires, Argentina
  • +5 more
May 10, 2023

Dry Eye Trial in United States (0.25% HL036 Ophthalmic Solution, Placebo)

Completed
  • Dry Eye
  • 0.25% HL036 Ophthalmic Solution
  • Placebo
  • Phoenix, Arizona
  • +9 more
Jan 4, 2023

Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)

Completed
  • Dry Eye Disease
  • CequaTM (Cyclosporine 0.09%) ophthalmic solution
  • Fort Myers, Florida
  • +4 more
Sep 8, 2022

Epiphora, Dacryostenosis, Dacryocystitis Trial in New Orleans (Proparacaine Hydrochloride ophthalmic solution, USP 0.5%,

Recruiting
  • Epiphora
  • +2 more
  • Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
  • Balanced salt solution
  • New Orleans, Louisiana
    Louisiana State University Health Sciences Center
Dec 15, 2022

Dry Eye Trial in United States (0.3% YP-P10 Ophthalmic Solution, 1% YP-P10 Ophthalmic Solution, YP-P10 Placebo Ophthalmic

Recruiting
  • Dry Eye
  • 0.3% YP-P10 Ophthalmic Solution
  • +2 more
  • Phoenix, Arizona
  • +6 more
Jul 15, 2022

Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)

Completed
Has Results
  • Dry Eye Disease
  • CyclASol topical ocular, eye drops
  • Vehicle topical ocular, eye drops
  • Newport Beach, California
  • +8 more
Dec 21, 2022

Elevated Intraocular Pressure Trial in United States (Latanoprost ophthalmic solution, 0.005%, TC-002 latanoprost ophthalmic

Active, not recruiting
  • Elevated Intraocular Pressure
  • Latanoprost ophthalmic solution, 0.005%
  • TC-002 latanoprost ophthalmic solution, 0.005%
  • Garden Grove, California
  • +19 more
May 23, 2022

Dry Eye Trial in Xiamen (HBM9036 0.25% Ophthalmic Solution, Placebo)

Recruiting
  • Dry Eye
  • HBM9036 0.25% Ophthalmic Solution
  • Placebo
  • Xiamen, Fujian, China
    Xiamen Eye Center of Xiamen University
Jun 16, 2022